Dialyzers Market Analysis | United States | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Pages: 48
  • Published Date: 11/1/2016
  • Type: MedCore

Product Description

Despite expected decreases in reimbursement for dialysis procedures, single-use dialyzers are expected to grow in prevalence. Single-use dialyzers do not require reprocessing machines or the labor requirement necessary for the reprocessing of reuse dialyzers. In 2016, the United States is one of the only developed countries that still use reuse dialyzers for a large fraction of the total hemodialysis treatments performed.

In the process of hemodialysis, the dialyzer performs the essential function of the kidney. During a hemodialysis treatment, the dialyzer will clean and remove the toxic substances from the blood. Blood can only be cleaned physically, not chemically. The patient’s blood is essentially filtered inside the dialyzer, and is channeled through the hollow fibers of the dialyzer. The walls of the hollow fibers consist of an ultra-thin membrane and various physical processes enable the removal of harmful molecules, while the critical elements of the blood are retained. The more exact a dialyzer and its membrane are at separating the important molecules from the harmful ones, the more effective the hemodialysis treatment will be.

Segments Covered in This Market

  • Single Use Dialyzer Market
  • Reuse Dialyzer Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the U.S. Dialyzer market, Fresnius was the leader, followed by Baxter and Nipro Medical. Fresenius maintained its position by marketing its Optiflux® Advanced Fresenius Polysulfone® and Hemoflow™ Polysulfone® dialyzers. Other companies analyzed inclyde Asahi Kasei Medical and B. Braun.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Dialysis Devices and Concentrates – MedSuite

Learn More about these product types
 

FREE Sample Report



The "US Market Report Suite for Dialysis Device and Concentrates 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Fresenius
Baxter
Rockwell Medical
Medivators
MarCor
Medisystems
B. Braun
Nipro Medical
Asahi Kasei Medical
Medcomp
Medtronic
Teleflex Medical
AmeriWater
Merit Medical Systems
C.R. Bard
Edwards Lifesciences
NxStage Medical
AngioDynamics
Tarumo
MEDRAD
W.L. Gore
Cook Medical
Kawasumi Laboratories
Lemaitre Vascular Inc.
Cordis
Boston Scientific
Abbott
Argon Medical
Atrium
Artegraft
Angelini Pharma Inc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

In the process of hemodialysis, the dialyzer performs the essential function of the kidney. During a hemodialysis treatment, the dialyzer will clean and remove the toxic substances from the blood. Blood can only be cleaned physically, not chemically. The patient’s blood is essentially filtered inside the dialyzer, and is channeled through the hollow fibers of the dialyzer. The walls of the hollow fibers consist of an ultra-thin membrane and various physical processes enable the removal of harmful molecules, while the critical elements of the blood are retained. The more exact a dialyzer and its membrane are at separating the important molecules from the harmful ones, the more effective the hemodialysis treatment will be.

  • 2017
  • 2013-2023
  • United States
  • 11/1/2016
  • 48
  • MedCore
SKU: iDATA_USDIA17_MC_DZ Categories: , , ,
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library